drag_handle
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Argentina-Developed Bio-Preservative Suppresses Mold in Baked Goods Using Bacteria-Derived Volatile Compounds
Argentine startup BioBlends has developed a bio-preservative that transports volatile organic compounds (VOCs) produced by bacteria in liquid form to inhibit mold growth in baked goods. Requiring no major modifications or additional investment in existing processing lines and having no impact on flavor or texture, it enables the clean label products consumers desire, achieving a shelf life of up to 55 days in laboratory testing. The company is validating its effectiveness in key markets, including the US, has signed Letters of Intent with top-five bakers, and is advancing its seed round funding.
AI-Enhanced Smartwatch-Based AHI Estimation and Validation of AI-Scored Polysomnography
Samsung Electronics' AI-based smartwatch (Galaxy Watch 6), developed and granted de novo approval by the FDA, has been demonstrated to measure apnea-hypopnea index (AHI) in real-world settings with accuracy equivalent to Level 1 polysomnography (PSG) in Korean adults. The study compared smartwatch data with PSG data from 53 subjects. The smartwatch-estimated AHI (eAHI) showed strong correlation (ρ=0.88, ICC=0.87) with the AI-processed PSG AHI (aiAHI), demonstrating high sensitivity and specificity, particularly for detecting and classifying moderate to severe obstructive sleep apnea (OSA). Although eAHI was slightly underestimated in mild OSA, its practical portability and continuous monitoring capability suggest potential as an auxiliary tool for early diagnosis and long-term management of OSA in clinical settings.
A pioneer in the field of ultrasound AI, the company has developed the world's first software for detecting deep vein thrombosis.
ThinkSono, a pioneering ultrasound AI company, has built the world's first software for DVT (blood clot) detection. For context, DVT is a leading cause of morbidity and mortality worldwide, and up to 900,000 people in the U.S are affected by DVT each year.
Wearable Textiles for Diabetes May Revolutionize Care
Already in use for monitoring patients with various types of cardiovascular disease, one of the most promising applications of smart textiles is their development for noninvasive glucose monitoring. The ability to provide patients with diabetes the same ease of use and flexibility that has shown to increase cardiac patients’ adherence to monitoring regimes could offer the same type of benefit in diabetes. Also, for patients with diabetes who have comorbidities, these textiles could allow the collection and integration of a variety of data directly into a patient’s electronic health record (EHR) at the clinician’s level.
Home-use EMS aids improvement in walking ability and muscle strength Enhanced walking function and reduced muscle mass loss confirmed in elderly cancer patients
A joint research team from MTG Co., Ltd. and Kansai Medical University conducted a 4-week pilot study to evaluate the effects of home-based rehabilitation using an EMS (electrical muscle stimulation) device on elderly cancer patients. The findings were published in the international journal Archives of Rehabilitation Research and Clinical Translation. The study was conducted at Kansai Medical University Hospital from March 2023 to July 2024. The subjects were 53 cancer patients, classified into a “lower limb dysfunction group” and a “normal group” based on SPPB scores, which evaluate walking speed, standing/sitting, and balance. Patients used EMS for 15 to 23 minutes daily over four weeks. As a result, the group with impaired lower limb function showed a significant improvement in SPPB scores, with particularly notable enhancements in balance ability and walking speed. Furthermore, the proportion of severe sarcopenia decreased significantly from 66.7% to 36.4%. MTG, whose mission is “Realizing VITAL LIFE,” develops EMS devices including SIXPAD. Cumulative shipments exceed 4 million units. While initially focused on fitness users, elderly adoption has increased in recent years, driven by lower-limb training products. Utilization is also expanding in rehabilitation fields through collaboration with nursing facilities and hospitals. Clinical insights are also accumulating, such as exercise therapy during dialysis treatment and improved prognosis for living liver transplant patients. Mr. Kumazaki from SIXPAD Headquarters' Medical Department commented, “Lower limb muscle strength becomes harder to build with age. Demonstrating improvement effects backed by evidence this time is significant. We aim to expand into Southeast Asia, where home-based needs are high.” EMS technology, expected to be applied to home rehabilitation, has shown potential to offer new options for maintaining health in an aging society.
Unilever Opens Fragrance Lab in Connecticut to Power Next-Gen Scent Innovation
The U.S. fragrance lab will serve as a hub for perfumers, scientists, and developers to create trend-driven, personalized scent experiences using AI, digital modeling, and advanced analytics. It includes facilities for fragrance blending, testing, and performance evaluation. The lab follows the debut of Unilever’s first in-house fragrance for the Dove Rose Berry Bouquet range and represents a key step in controlling end-to-end fragrance creation. It supports the company’s broader strategy to accelerate innovation and respond faster to consumer preferences in a major market.
Xerafy Launches Print-Ready Roll-Format RFID Tags for Laundry at The Clean Show 2025
Xerafy, the engineering leader in RFID for textile inventory control, will debut its latest innovation, the TEX TRAK Roll, at The Clean Show 2025, Booth #3415. As a member of the Textile Rental Services Association (TRSA) www.trsa.org and the RAIN Alliance https://therainalliance.org/, Xerafy continues to challenge legacy limitations with technology designed for real-world laundry operations. The TEX TRAK Roll introduces a new category of RFID laundry tags: durable, ultra-thin tags delivered in roll format and designed for on-demand printing using standard industrial RFID printers, with leading printer manufacturers Zebra, SATO, and TSC already on board.
New device could allow you to taste a cake in virtual reality
Novel technology intends to redefine the virtual reality experience by expanding to incorporate a new sensory connection: taste. The interface, dubbed ‘e-Taste’, uses a combination of sensors and wireless chemical dispensers to facilitate the remote perception of taste – what scientists call gustation. These sensors are attuned to recognize molecules like glucose and glutamate — chemicals that represent the five basic tastes of sweet, sour, salty, bitter, and umami. Once captured via an electrical signal, that data is wirelessly passed to a remote device for replication. Field testing done by researchers at The Ohio State University confirmed the device’s ability to digitally simulate a range of taste intensities, while still offering variety and safety for the user.
First-ever home-based digital technology approved for cardiac rehabilitation
The UK's National Institute for Health and Care Excellence (NICE) has approved six digital technologies for cardiac resynchronization (cardiac rehabilitation) for the first time.These technologies enable patients to undertake rehabilitation at home. The approved technologies are Activate Your Heart, D REACH-HF, Digital Heart Manual, Gro Health HeartBuddy, KiActiv, and myHeart. They provide exercise programs, education on cardiovascular disease (CVD), medication management, and psychological support. These technologies have a three-year data collection period to assess their long-term effectiveness.CVD is the second leading cause of death in the UK, affecting over 7.6 million people. While uptake of traditional cardiac rehabilitation is low, digital technologies can overcome access and scheduling barriers, particularly benefiting women, younger people, ethnic minorities, and those in economically disadvantaged areas. However, not all technologies are suitable for every patient, and assessment by healthcare professionals is required.
Plastics Recycling With Enzymes Takes a Leap Forward
A successful collaboration involving a trio of research institutions has yielded a road map toward an economically viable process for using enzymes to recycle plastics. The researchers, from NREL, the University of Massachusetts Lowell, and the University of Portsmouth in England, previously partnered on the biological engineering of improved PETase enzymes that can break down polyethylene terephthalate (PET). With its low manufacturing cost and excellent material properties, PET is used extensively in single-use packaging, soda bottles, and textiles. The new study combines the previous fundamental research with advanced chemical engineering, process development, and techno-economic analysis to lay the blueprints for enzyme-based PET recycling at industrial scale.
King's Surgeons Trial New Robotic System for Throat Cancer Surgery
Surgeons at King's Hospital have conducted a clinical trial of transoral robotic surgery (TORS) for the treatment of laryngeal cancer using the Versius robotic surgery system developed by CMR Surgical in the UK.Over an 8-month period, 30 surgeries were successfully completed, including 15 cases of benign conditions and 15 cases of cancer. This study marks a significant step forward in expanding the options for robotic surgery in head and neck cancer treatment by introducing a new robotic platform for TORS. The study was conducted under the IDEAL framework, progressing from benign cases to cancer surgery.The four-arm robotic surgery system offers a novel approach not achievable with other multi-port systems, contributing to improved surgical access and reduced assistant workload. However, challenges were encountered in narrow spaces such as the base of the tongue. Future improvements include the development of specialized TORS instruments, particularly monopolar sputum extractors. The research team recommends further multi-center studies and suggests that Versius could offer a more accessible and cost-effective alternative compared to existing robotic platforms.
New device could allow you to taste a cake in virtual reality
Novel technology intends to redefine the virtual reality experience by expanding to incorporate a new sensory connection: taste. The interface, dubbed ‘e-Taste’, uses a combination of sensors and wireless chemical dispensers to facilitate the remote perception of taste – what scientists call gustation. These sensors are attuned to recognize molecules like glucose and glutamate — chemicals that represent the five basic tastes of sweet, sour, salty, bitter, and umami. Once captured via an electrical signal, that data is wirelessly passed to a remote device for replication. Field testing done by researchers at The Ohio State University confirmed the device’s ability to digitally simulate a range of taste intensities, while still offering variety and safety for the user.
FDA Grants Breakthrough Device Designation for HeartSciences' AI-ECG Algorithm
HeartSciences Inc. has announced that the U.S. Food and Drug Administration has granted Breakthrough Device designation for its Aortic Stenosis (“AS”) ECG algorithm. Aortic Stenosis is one of the most serious and common heart valve diseases, often progressing silently and leading to severe, life-threatening outcomes if left undetected. Early symptoms are frequently vague or absent, resulting in delayed diagnosis and treatment. If unrecognized, AS can cause irreversible myocardial damage and significant deterioration in cardiac function. The algorithm would offer a novel, AI-driven ECG solution capable of detecting moderate-to-severe aortic stenosis. Once cleared by the FDA, the algorithm will be accessible through HeartSciences' MyoVista Insights cloud-based platform which would directly integrate with hospital electronic health record (EHR) systems, requiring no additional hardware or testing.
DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
DigitalMedical Open Innovation
デジタル・メディカル・オープンイノベーション
BrainEnergy produce DigitalMedical open innovation from Tokyo, where you can experience the intersection of cool and passionate design and technology.
Transform Your Business With Cloud
Looking for the Future
of Health Care
OUR TECHNOLOGY HELPS
YOUR BUSINESS
Our technology will help your business
Technology
Argentina-Developed Bio-Preservative Suppresses Mold in Baked Goods Using Bacteria-Derived Volatile Compounds
Argentine startup BioBlends has developed a bio-preservative that transports volatile organic compounds (VOCs) produced by bacteria in liquid form to inhibit mold growth in baked goods. Requiring no major modifications or additional investment in existing processing lines and having no impact on flavor or texture, it enables the clean label products consumers desire, achieving a shelf life of up to 55 days in laboratory testing. The company is validating its effectiveness in key markets, including the US, has signed Letters of Intent with top-five bakers, and is advancing its seed round funding.
AgFunderNews
AI-Enhanced Smartwatch-Based AHI Estimation and Validation of AI-Scored Polysomnography
Samsung Electronics' AI-based smartwatch (Galaxy Watch 6), developed and granted de novo approval by the FDA, has been demonstrated to measure apnea-hypopnea index (AHI) in real-world settings with accuracy equivalent to Level 1 polysomnography (PSG) in Korean adults. The study compared smartwatch data with PSG data from 53 subjects. The smartwatch-estimated AHI (eAHI) showed strong correlation (ρ=0.88, ICC=0.87) with the AI-processed PSG AHI (aiAHI), demonstrating high sensitivity and specificity, particularly for detecting and classifying moderate to severe obstructive sleep apnea (OSA). Although eAHI was slightly underestimated in mild OSA, its practical portability and continuous monitoring capability suggest potential as an auxiliary tool for early diagnosis and long-term management of OSA in clinical settings.
Dove Medical Press
A pioneer in the field of ultrasound AI, the company has developed the world's first software for detecting deep vein thrombosis.
ThinkSono, a pioneering ultrasound AI company, has built the world's first software for DVT (blood clot) detection. For context, DVT is a leading cause of morbidity and mortality worldwide, and up to 900,000 people in the U.S are affected by DVT each year.
Access newswire
Wearable Textiles for Diabetes May Revolutionize Care
Already in use for monitoring patients with various types of cardiovascular disease, one of the most promising applications of smart textiles is their development for noninvasive glucose monitoring. The ability to provide patients with diabetes the same ease of use and flexibility that has shown to increase cardiac patients’ adherence to monitoring regimes could offer the same type of benefit in diabetes. Also, for patients with diabetes who have comorbidities, these textiles could allow the collection and integration of a variety of data directly into a patient’s electronic health record (EHR) at the clinician’s level.
Medscape
Home-use EMS aids improvement in walking ability and muscle strength Enhanced walking function and reduced muscle mass loss confirmed in elderly cancer patients
A joint research team from MTG Co., Ltd. and Kansai Medical University conducted a 4-week pilot study to evaluate the effects of home-based rehabilitation using an EMS (electrical muscle stimulation) device on elderly cancer patients. The findings were published in the international journal Archives of Rehabilitation Research and Clinical Translation. The study was conducted at Kansai Medical University Hospital from March 2023 to July 2024. The subjects were 53 cancer patients, classified into a “lower limb dysfunction group” and a “normal group” based on SPPB scores, which evaluate walking speed, standing/sitting, and balance. Patients used EMS for 15 to 23 minutes daily over four weeks. As a result, the group with impaired lower limb function showed a significant improvement in SPPB scores, with particularly notable enhancements in balance ability and walking speed. Furthermore, the proportion of severe sarcopenia decreased significantly from 66.7% to 36.4%. MTG, whose mission is “Realizing VITAL LIFE,” develops EMS devices including SIXPAD. Cumulative shipments exceed 4 million units. While initially focused on fitness users, elderly adoption has increased in recent years, driven by lower-limb training products. Utilization is also expanding in rehabilitation fields through collaboration with nursing facilities and hospitals. Clinical insights are also accumulating, such as exercise therapy during dialysis treatment and improved prognosis for living liver transplant patients. Mr. Kumazaki from SIXPAD Headquarters' Medical Department commented, “Lower limb muscle strength becomes harder to build with age. Demonstrating improvement effects backed by evidence this time is significant. We aim to expand into Southeast Asia, where home-based needs are high.” EMS technology, expected to be applied to home rehabilitation, has shown potential to offer new options for maintaining health in an aging society.
DxMedical Cloud™︎
Unilever Opens Fragrance Lab in Connecticut to Power Next-Gen Scent Innovation
The U.S. fragrance lab will serve as a hub for perfumers, scientists, and developers to create trend-driven, personalized scent experiences using AI, digital modeling, and advanced analytics. It includes facilities for fragrance blending, testing, and performance evaluation. The lab follows the debut of Unilever’s first in-house fragrance for the Dove Rose Berry Bouquet range and represents a key step in controlling end-to-end fragrance creation. It supports the company’s broader strategy to accelerate innovation and respond faster to consumer preferences in a major market.
Global Cosmetics News
Xerafy Launches Print-Ready Roll-Format RFID Tags for Laundry at The Clean Show 2025
Xerafy, the engineering leader in RFID for textile inventory control, will debut its latest innovation, the TEX TRAK Roll, at The Clean Show 2025, Booth #3415. As a member of the Textile Rental Services Association (TRSA) www.trsa.org and the RAIN Alliance https://therainalliance.org/, Xerafy continues to challenge legacy limitations with technology designed for real-world laundry operations. The TEX TRAK Roll introduces a new category of RFID laundry tags: durable, ultra-thin tags delivered in roll format and designed for on-demand printing using standard industrial RFID printers, with leading printer manufacturers Zebra, SATO, and TSC already on board.
CBS4
New device could allow you to taste a cake in virtual reality
Novel technology intends to redefine the virtual reality experience by expanding to incorporate a new sensory connection: taste. The interface, dubbed ‘e-Taste’, uses a combination of sensors and wireless chemical dispensers to facilitate the remote perception of taste – what scientists call gustation. These sensors are attuned to recognize molecules like glucose and glutamate — chemicals that represent the five basic tastes of sweet, sour, salty, bitter, and umami. Once captured via an electrical signal, that data is wirelessly passed to a remote device for replication. Field testing done by researchers at The Ohio State University confirmed the device’s ability to digitally simulate a range of taste intensities, while still offering variety and safety for the user.
osu.edu
First-ever home-based digital technology approved for cardiac rehabilitation
The UK's National Institute for Health and Care Excellence (NICE) has approved six digital technologies for cardiac resynchronization (cardiac rehabilitation) for the first time.These technologies enable patients to undertake rehabilitation at home. The approved technologies are Activate Your Heart, D REACH-HF, Digital Heart Manual, Gro Health HeartBuddy, KiActiv, and myHeart. They provide exercise programs, education on cardiovascular disease (CVD), medication management, and psychological support. These technologies have a three-year data collection period to assess their long-term effectiveness.CVD is the second leading cause of death in the UK, affecting over 7.6 million people. While uptake of traditional cardiac rehabilitation is low, digital technologies can overcome access and scheduling barriers, particularly benefiting women, younger people, ethnic minorities, and those in economically disadvantaged areas. However, not all technologies are suitable for every patient, and assessment by healthcare professionals is required.
The Pharmaceutical Journal
Plastics Recycling With Enzymes Takes a Leap Forward
A successful collaboration involving a trio of research institutions has yielded a road map toward an economically viable process for using enzymes to recycle plastics. The researchers, from NREL, the University of Massachusetts Lowell, and the University of Portsmouth in England, previously partnered on the biological engineering of improved PETase enzymes that can break down polyethylene terephthalate (PET). With its low manufacturing cost and excellent material properties, PET is used extensively in single-use packaging, soda bottles, and textiles. The new study combines the previous fundamental research with advanced chemical engineering, process development, and techno-economic analysis to lay the blueprints for enzyme-based PET recycling at industrial scale.
Clean Technica
King's Surgeons Trial New Robotic System for Throat Cancer Surgery
Surgeons at King's Hospital have conducted a clinical trial of transoral robotic surgery (TORS) for the treatment of laryngeal cancer using the Versius robotic surgery system developed by CMR Surgical in the UK.Over an 8-month period, 30 surgeries were successfully completed, including 15 cases of benign conditions and 15 cases of cancer. This study marks a significant step forward in expanding the options for robotic surgery in head and neck cancer treatment by introducing a new robotic platform for TORS. The study was conducted under the IDEAL framework, progressing from benign cases to cancer surgery.The four-arm robotic surgery system offers a novel approach not achievable with other multi-port systems, contributing to improved surgical access and reduced assistant workload. However, challenges were encountered in narrow spaces such as the base of the tongue. Future improvements include the development of specialized TORS instruments, particularly monopolar sputum extractors. The research team recommends further multi-center studies and suggests that Versius could offer a more accessible and cost-effective alternative compared to existing robotic platforms.
King's College London
New device could allow you to taste a cake in virtual reality
Novel technology intends to redefine the virtual reality experience by expanding to incorporate a new sensory connection: taste. The interface, dubbed ‘e-Taste’, uses a combination of sensors and wireless chemical dispensers to facilitate the remote perception of taste – what scientists call gustation. These sensors are attuned to recognize molecules like glucose and glutamate — chemicals that represent the five basic tastes of sweet, sour, salty, bitter, and umami. Once captured via an electrical signal, that data is wirelessly passed to a remote device for replication. Field testing done by researchers at The Ohio State University confirmed the device’s ability to digitally simulate a range of taste intensities, while still offering variety and safety for the user.
osu.edu
FDA Grants Breakthrough Device Designation for HeartSciences' AI-ECG Algorithm
HeartSciences Inc. has announced that the U.S. Food and Drug Administration has granted Breakthrough Device designation for its Aortic Stenosis (“AS”) ECG algorithm. Aortic Stenosis is one of the most serious and common heart valve diseases, often progressing silently and leading to severe, life-threatening outcomes if left undetected. Early symptoms are frequently vague or absent, resulting in delayed diagnosis and treatment. If unrecognized, AS can cause irreversible myocardial damage and significant deterioration in cardiac function. The algorithm would offer a novel, AI-driven ECG solution capable of detecting moderate-to-severe aortic stenosis. Once cleared by the FDA, the algorithm will be accessible through HeartSciences' MyoVista Insights cloud-based platform which would directly integrate with hospital electronic health record (EHR) systems, requiring no additional hardware or testing.
DAIC